Journal of Neurology Neurosurgery & Psychiatry · 1984 · 35 citations · 7 references
PharmacyNeurologyPharmacotherapyClinical NeuroscienceEndocrine PharmacotherapyAmyotrophic Lateral SclerosisHormone ReleaseNeurodegenerative Disease PharmacotherapyAmyotrophic Lateral Sclerosis PathologyDouble-blind TrialsObjective EvaluationTherapeutic Effectiveness
A double-blind crossover trial was conducted of thyrotropin releasing hormone treatment in six patients with amyotrophic lateral sclerosis. Patients received 4 mg of thyrotropin releasing hormone intramuscularly daily during the two-week treatment period. Although three patients reported subjective improvement, objective evaluation failed to demonstrate therapeutic effectiveness of thyrotropin releasing hormone in this dosage.
7
Thyrotropin-Releasing Hormone: Regional Distribution in Rat Brain
Andrew Winokur, Robert D. Utiger · Science · 1974 · 422 citations